Back to Journals » Neuropsychiatric Disease and Treatment » Volume 6 » Supplement 1

Milnacipran: recent findings in depression

Authors Briley M

Published 24 August 2010 Volume 2010:6(Supplement 1)

DOI https://doi.org/10.2147/NDT.S11772


EDITORIAL FOREWORD
Page 1  
Milnacipran: recent findings in depression 
Stuart Montgomery (London, UK) and Mike Briley (Castres, France)
REVIEWS
Page 3  
Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran 
Philippe Courtet (Montpellier, France)
Page 9  
Treatment of patients with comorbid depression and diabetes with metformin and milnacipran 
Peter Hofmann (Graz, Austria)
Page 17 
Antidepressant therapy with milnacipran and venlafaxine 
Lucilla Mansuy (Toulouse, France)
Page 23 
Milnacipran: a unique antidepressant? 
Siegfried Kasper and Gerald Pail (Vienna, Austria)
 
This supplement is based on a symposium that took place at the 9th International Forum on Mood and Anxiety in Monte Carlo in November 2009 and is supported by an unconditional education grant from Pierre Fabre Médicament.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]